Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 28 entries
Sorted by: Best Match Show Resources per page
Immunological Disorders:(a) Food Allergy and Hypersensitivity

community settings

Hourihane JOB.
GSID: lXonyR36VeoJ
JOB Hourihane - Yamada's Textbook of Gastroenterology, 2015 - Wiley Online Library

The increasing prevalence of food allergy and other atopic disorders and the exponential demand for allergy evaluation means there is enormous opportunity for both clinical practice …

Cite
Hourihane, J. O. B. (2015). Immunological Disorders:(a) Food Allergy and Hypersensitivity. Yamada's Textbook of Gastroenterology, 2297-2302.
Hourihane, Jonathan O'B. "Immunological Disorders:(a) Food Allergy and Hypersensitivity." Yamada's Textbook of Gastroenterology (2015): 2297-2302.
Copy Download .nbib Format: MLA
Risk multipliers for severe food anaphylaxis.

The World Allergy Organization journal

Smith PK, Hourihane JO, Lieberman P.
PMID: 26635908
World Allergy Organ J. 2015 Nov 24;8(1):30. doi: 10.1186/s40413-015-0081-0. eCollection 2015.

Anaphylaxis is a severe, life threatening allergic reaction. In most fatal cases of food anaphylaxis, the fatality is not due merely to a simple, linear relationship between the allergen and exposure in a sensitized individual. Compounding factors such as...

Cite
Smith PK, Hourihane JO, Lieberman P. Risk multipliers for severe food anaphylaxis. World Allergy Organ J. 2015;8(1):30doi: 10.1186/s40413-015-0081-0.
Smith, P. K., Hourihane, J. O., & Lieberman, P. (2015). Risk multipliers for severe food anaphylaxis. The World Allergy Organization journal, 8(1), 30. https://doi.org/10.1186/s40413-015-0081-0
Smith, Peter K, et al. "Risk multipliers for severe food anaphylaxis." The World Allergy Organization journal vol. 8,1 (2015): 30. doi: https://doi.org/10.1186/s40413-015-0081-0
Smith PK, Hourihane JO, Lieberman P. Risk multipliers for severe food anaphylaxis. World Allergy Organ J. 2015 Nov 24;8(1):30. doi: 10.1186/s40413-015-0081-0. eCollection 2015. PMID: 26635908; PMCID: PMC4657220.
Copy Download .nbib Format: NLM
A virtual management approach to infant egg allergy developed in response to pandemic-imposed restrictions.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Mac Mahon J, Hourihane JO, Byrne A.
PMID: 33244828
Clin Exp Allergy. 2021 Feb;51(2):360-363. doi: 10.1111/cea.13794. Epub 2021 Jan 07.

No abstract available.

Cite
Mac Mahon J, Hourihane JO, Byrne A. A virtual management approach to infant egg allergy developed in response to pandemic-imposed restrictions. Clin Exp Allergy. 2021;51(2):360-363doi: 10.1111/cea.13794.
Mac Mahon, J., Hourihane, J. O., & Byrne, A. (2021). A virtual management approach to infant egg allergy developed in response to pandemic-imposed restrictions. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 51(2), 360-363. https://doi.org/10.1111/cea.13794
Mac Mahon, Jayne, et al. "A virtual management approach to infant egg allergy developed in response to pandemic-imposed restrictions." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 51,2 (2021): 360-363. doi: https://doi.org/10.1111/cea.13794
Mac Mahon J, Hourihane JO, Byrne A. A virtual management approach to infant egg allergy developed in response to pandemic-imposed restrictions. Clin Exp Allergy. 2021 Feb;51(2):360-363. doi: 10.1111/cea.13794. Epub 2021 Jan 07. PMID: 33244828; PMCID: PMC7753832.
Copy Download .nbib Format: NLM
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi DP, Camargos PA, Canonica GW, Casale T, Chavannes NH, Cruz AA, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens WJ, Guldemond NA, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O'Hehir RE, Papadopoulos NG, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann HJ, Sheikh A, Simons FE, Stellato C, Todo-Bom A, Tomazic PV, Valiulis A, Valovirta E, Ventura MT, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis CA, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui IJ, Anto JM, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman ED, Beghé B, Bel EH, Bennoor KS, Benson M, Białoszewski AZ, Bieber T, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon MA, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo AM, Carlsen KH, Carr W, Cepeda Sarabia AM, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, de Sousa JC, Cox L, Crooks G, Custovic A, Dahlen SE, Darsow U, Dedeu T, Deleanu D, Denburg JA, De Vries G, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda JE, van Wick RG, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán MA, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Humbert M, Hyland M, Iaccarino G, Jares EJ, Jeandel C, Johnston SL, Joos G, Jonquet O, Jung KS, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu AF, Kardas P, Keith PK, Kerkhof M, Kerstjens HA, Khaltaev N, Kogevinas M, Kolek V, Koppelman GH, Kowalski ML, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen KC, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park HS, Passalacqua G, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Poulsen LK, Price D, Rabe KF, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona LL, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang DY, Wahn U, Werfel T, Whalley B, Williams DM, Williams S, Wilson N, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M.
PMID: 28050247
Clin Transl Allergy. 2016 Dec 30;6:47. doi: 10.1186/s13601-016-0137-4. eCollection 2016.

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in...

Cite
Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47doi: 10.1186/s13601-016-0137-4.
Bousquet, J., Hellings, P. W., Agache, I., Bedbrook, A., Bachert, C., Bergmann, K. C., Bewick, M., Bindslev-Jensen, C., Bosnic-Anticevitch, S., Bucca, C., Caimmi, D. P., Camargos, P. A., Canonica, G. W., Casale, T., Chavannes, N. H., Cruz, A. A., De Carlo, G., Dahl, R., Demoly, P., Devillier, P., Fonseca, J., Fokkens, W. J., Guldemond, N. A., Haahtela, T., Illario, M., Just, J., Keil, T., Klimek, L., Kuna, P., Larenas-Linnemann, D., Morais-Almeida, M., Mullol, J., Murray, R., Naclerio, R., O'Hehir, R. E., Papadopoulos, N. G., Pawankar, R., Potter, P., Ryan, D., Samolinski, B., Schunemann, H. J., Sheikh, A., Simons, F. E., Stellato, C., Todo-Bom, A., Tomazic, P. V., Valiulis, A., Valovirta, E., Ventura, M. T., Wickman, M., Young, I., Yorgancioglu, A., Zuberbier, T., Aberer, W., Akdis, C. A., Akdis, M., Annesi-Maesano, I., Ankri, J., Ansotegui, I. J., Anto, J. M., Arnavielhe, S., Asarnoj, A., Arshad, H., Avolio, F., Baiardini, I., Barbara, C., Barbagallo, M., Bateman, E. D., Beghé, B., Bel, E. H., Bennoor, K. S., Benson, M., Białoszewski, A. Z., Bieber, T., Bjermer, L., Blain, H., Blasi, F., Boner, A. L., Bonini, M., Bonini, S., Bosse, I., Bouchard, J., Boulet, L. P., Bourret, R., Bousquet, P. J., Braido, F., Briggs, A. H., Brightling, C. E., Brozek, J., Buhl, R., Bunu, C., Burte, E., Bush, A., Caballero-Fonseca, F., Calderon, M. A., Camuzat, T., Cardona, V., Carreiro-Martins, P., Carriazo, A. M., Carlsen, K. H., Carr, W., Cepeda Sarabia, A. M., Cesari, M., Chatzi, L., Chiron, R., Chivato, T., Chkhartishvili, E., Chuchalin, A. G., Chung, K. F., Ciprandi, G., de Sousa, J. C., Cox, L., Crooks, G., Custovic, A., Dahlen, S. E., Darsow, U., Dedeu, T., Deleanu, D., Denburg, J. A., De Vries, G., Didier, A., Dinh-Xuan, A. T., Dokic, D., Douagui, H., Dray, G., Dubakiene, R., Durham, S. R., Du Toit, G., Dykewicz, M. S., Eklund, P., El-Gamal, Y., Ellers, E., Emuzyte, R., Farrell, J., Fink Wagner, A., Fiocchi, A., Fletcher, M., Forastiere, F., Gaga, M., Gamkrelidze, A., Gemicioğlu, B., Gereda, J. E., van Wick, R. G., González Diaz, S., Grisle, I., Grouse, L., Gutter, Z., Guzmán, M. A., Hellquist-Dahl, B., Heinrich, J., Horak, F., Hourihane, J. O., Humbert, M., Hyland, M., Iaccarino, G., Jares, E. J., Jeandel, C., Johnston, S. L., Joos, G., Jonquet, O., Jung, K. S., Jutel, M., Kaidashev, I., Khaitov, M., Kalayci, O., Kalyoncu, A. F., Kardas, P., Keith, P. K., Kerkhof, M., Kerstjens, H. A., Khaltaev, N., Kogevinas, M., Kolek, V., Koppelman, G. H., Kowalski, M. L., Kuitunen, M., Kull, I., Kvedariene, V., Lambrecht, B., Lau, S., Laune, D., Le, L. T., Lieberman, P., Lipworth, B., Li, J., Lodrup Carlsen, K. C., Louis, R., Lupinek, C., MacNee, W., Magar, Y., Magnan, A., Mahboub, B., Maier, D., Majer, I., Malva, J., Manning, P., De Manuel Keenoy, E., Marshall, G. D., Masjedi, M. R., Mathieu-Dupas, E., Maurer, M., Mavale-Manuel, S., Melén, E., Melo-Gomes, E., Meltzer, E. O., Mercier, J., Merk, H., Miculinic, N., Mihaltan, F., Milenkovic, B., Millot-Keurinck, J., Mohammad, Y., Momas, I., Mösges, R., Muraro, A., Namazova-Baranova, L., Nadif, R., Neffen, H., Nekam, K., Nieto, A., Niggemann, B., Nogueira-Silva, L., Nogues, M., Nyembue, T. D., Ohta, K., Okamoto, Y., Okubo, K., Olive-Elias, M., Ouedraogo, S., Paggiaro, P., Pali-Schöll, I., Palkonen, S., Panzner, P., Papi, A., Park, H. S., Passalacqua, G., Pedersen, S., Pereira, A. M., Pfaar, O., Picard, R., Pigearias, B., Pin, I., Plavec, D., Pohl, W., Popov, T. A., Portejoie, F., Postma, D., Poulsen, L. K., Price, D., Rabe, K. F., Raciborski, F., Roberts, G., Robalo-Cordeiro, C., Rodenas, F., Rodriguez-Mañas, L., Rolland, C., Roman Rodriguez, M., Romano, A., Rosado-Pinto, J., Rosario, N., Rottem, M., Sanchez-Borges, M., Sastre-Dominguez, J., Scadding, G. K., Scichilone, N., Schmid-Grendelmeier, P., Serrano, E., Shields, M., Siroux, V., Sisul, J. C., Skrindo, I., Smit, H. A., Solé, D., Sooronbaev, T., Spranger, O., Stelmach, R., Sterk, P. J., Strandberg, T., Sunyer, J., Thijs, C., Triggiani, M., Valenta, R., Valero, A., van Eerd, M., van Ganse, E., van Hague, M., Vandenplas, O., Varona, L. L., Vellas, B., Vezzani, G., Vazankari, T., Viegi, G., Vontetsianos, T., Wagenmann, M., Walker, S., Wang, D. Y., Wahn, U., Werfel, T., Whalley, B., Williams, D. M., Williams, S., Wilson, N., Wright, J., Yawn, B. P., Yiallouros, P. K., Yusuf, O. M., Zaidi, A., Zar, H. J., Zernotti, M. E., Zhang, L., Zhong, N., & Zidarn, M. (2016). ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clinical and translational allergy, 647. https://doi.org/10.1186/s13601-016-0137-4
Bousquet, J, et al. "ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle." Clinical and translational allergy vol. 6 (2016): 47. doi: https://doi.org/10.1186/s13601-016-0137-4
Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi DP, Camargos PA, Canonica GW, Casale T, Chavannes NH, Cruz AA, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens WJ, Guldemond NA, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O'Hehir RE, Papadopoulos NG, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann HJ, Sheikh A, Simons FE, Stellato C, Todo-Bom A, Tomazic PV, Valiulis A, Valovirta E, Ventura MT, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis CA, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui IJ, Anto JM, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman ED, Beghé B, Bel EH, Bennoor KS, Benson M, Białoszewski AZ, Bieber T, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon MA, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo AM, Carlsen KH, Carr W, Cepeda Sarabia AM, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, de Sousa JC, Cox L, Crooks G, Custovic A, Dahlen SE, Darsow U, Dedeu T, Deleanu D, Denburg JA, De Vries G, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda JE, van Wick RG, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán MA, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Humbert M, Hyland M, Iaccarino G, Jares EJ, Jeandel C, Johnston SL, Joos G, Jonquet O, Jung KS, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu AF, Kardas P, Keith PK, Kerkhof M, Kerstjens HA, Khaltaev N, Kogevinas M, Kolek V, Koppelman GH, Kowalski ML, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen KC, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park HS, Passalacqua G, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Poulsen LK, Price D, Rabe KF, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona LL, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang DY, Wahn U, Werfel T, Whalley B, Williams DM, Williams S, Wilson N, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016 Dec 30;6:47. doi: 10.1186/s13601-016-0137-4. eCollection 2016. PMID: 28050247; PMCID: PMC5203711.
Copy Download .nbib Format: NLM
A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial.

BMJ open

Kelleher MM, Hourihane JO, Dunngalvin A, Cullinane C, Fitzsimons J, Sheikh A.
PMID: 22893666
BMJ Open. 2012 Aug 13;2(4). doi: 10.1136/bmjopen-2012-001282. Print 2012.

OBJECTIVES: Anaphylaxis is an important, potentially life-threatening paediatric emergency. It is responsible for considerable morbidity and, in some cases, death. Poor outcomes may be associated with an inability to differentiate between milder and potentially more severe reactions and an...

Cite
Kelleher MM, Hourihane JO, Dunngalvin A, et al. A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial. BMJ Open. 2012;2(4)doi: 10.1136/bmjopen-2012-001282.
Kelleher, M. M., Hourihane, J. O., Dunngalvin, A., Cullinane, C., Fitzsimons, J., & Sheikh, A. (2012). A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial. BMJ open, 2(4), . https://doi.org/10.1136/bmjopen-2012-001282
Kelleher, Maeve M, et al. "A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial." BMJ open vol. 2,4 (2012). doi: https://doi.org/10.1136/bmjopen-2012-001282
Kelleher MM, Hourihane JO, Dunngalvin A, Cullinane C, Fitzsimons J, Sheikh A. A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial. BMJ Open. 2012 Aug 13;2(4). doi: 10.1136/bmjopen-2012-001282. Print 2012. PMID: 22893666; PMCID: PMC3425896.
Copy Download .nbib Format: NLM
Managing Food Allergy When the Patient Is Not Highly Allergic.

The journal of allergy and clinical immunology. In practice

Sicherer SH, Abrams EM, Nowak-Wegrzyn A, Hourihane JO.
PMID: 34098164
J Allergy Clin Immunol Pract. 2021 Jun 05; doi: 10.1016/j.jaip.2021.05.021. Epub 2021 Jun 05.

Few patients with food allergy are "highly allergic," meaning they always have severe reactions and always react to very small amounts of allergen. Standard medical approaches for allergy management have focused on the safety and lifestyle modifications this group...

Cite
Sicherer SH, Abrams EM, Nowak-Wegrzyn A, et al. Managing Food Allergy When the Patient Is Not Highly Allergic. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.05.021.
Sicherer, S. H., Abrams, E. M., Nowak-Wegrzyn, A., & Hourihane, J. O. (2021). Managing Food Allergy When the Patient Is Not Highly Allergic. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.05.021
Sicherer, Scott H, et al. "Managing Food Allergy When the Patient Is Not Highly Allergic." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.05.021
Sicherer SH, Abrams EM, Nowak-Wegrzyn A, Hourihane JO. Managing Food Allergy When the Patient Is Not Highly Allergic. J Allergy Clin Immunol Pract. 2021 Jun 05; doi: 10.1016/j.jaip.2021.05.021. Epub 2021 Jun 05. PMID: 34098164.
Copy Download .nbib Format: NLM
Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial.

Clinical and translational allergy

Boyle R, Brown N, Chiang WC, Chien CM, Gold M, Hourihane J, Peake J, Quinn P, Rao R, Smith P, Tang M, Ziegler J, Warner J.
PMID: 33524077
Clin Transl Allergy. 2020 Nov 09;10:48. doi: 10.1186/s13601-020-00356-5. eCollection 2020.

[This retracts the article DOI: 10.1186/2045-7022-5-S3-P30.].

Cite
Boyle R, Brown N, Chiang WC, et al. Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Clin Transl Allergy. 2020;10:48doi: 10.1186/s13601-020-00356-5.
Boyle, R., Brown, N., Chiang, W. C., Chien, C. M., Gold, M., Hourihane, J., Peake, J., Quinn, P., Rao, R., Smith, P., Tang, M., Ziegler, J., & Warner, J. (2020). Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Clinical and translational allergy, 1048. https://doi.org/10.1186/s13601-020-00356-5
Boyle, Robert, et al. "Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial." Clinical and translational allergy vol. 10 (2020): 48. doi: https://doi.org/10.1186/s13601-020-00356-5
Boyle R, Brown N, Chiang WC, Chien CM, Gold M, Hourihane J, Peake J, Quinn P, Rao R, Smith P, Tang M, Ziegler J, Warner J. Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Clin Transl Allergy. 2020 Nov 09;10:48. doi: 10.1186/s13601-020-00356-5. eCollection 2020. PMID: 33524077; PMCID: PMC7653747.
Copy Download .nbib Format: NLM
Managing Food Allergy When the Patient Is Not Highly Allergic.

The journal of allergy and clinical immunology. In practice

Sicherer SH, Abrams EM, Nowak-Wegrzyn A, Hourihane JO.
PMID: 34098164
J Allergy Clin Immunol Pract. 2022 Jan;10(1):46-55. doi: 10.1016/j.jaip.2021.05.021. Epub 2021 Jun 05.

Few patients with food allergy are "highly allergic," meaning they always have severe reactions and always react to very small amounts of allergen. Standard medical approaches for allergy management have focused on the safety and lifestyle modifications this group...

Cite
Sicherer SH, Abrams EM, Nowak-Wegrzyn A, et al. Managing Food Allergy When the Patient Is Not Highly Allergic. J Allergy Clin Immunol Pract. 2021;10(1):46-55doi: 10.1016/j.jaip.2021.05.021.
Sicherer, S. H., Abrams, E. M., Nowak-Wegrzyn, A., & Hourihane, J. O. (2022). Managing Food Allergy When the Patient Is Not Highly Allergic. The journal of allergy and clinical immunology. In practice, 10(1), 46-55. https://doi.org/10.1016/j.jaip.2021.05.021
Sicherer, Scott H, et al. "Managing Food Allergy When the Patient Is Not Highly Allergic." The journal of allergy and clinical immunology. In practice vol. 10,1 (2022): 46-55. doi: https://doi.org/10.1016/j.jaip.2021.05.021
Sicherer SH, Abrams EM, Nowak-Wegrzyn A, Hourihane JO. Managing Food Allergy When the Patient Is Not Highly Allergic. J Allergy Clin Immunol Pract. 2022 Jan;10(1):46-55. doi: 10.1016/j.jaip.2021.05.021. Epub 2021 Jun 05. PMID: 34098164.
Copy Download .nbib Format: NLM
Differential phase register of Hes1 oscillations with mitoses underlies cell-cycle heterogeneity in ER.

Proceedings of the National Academy of Sciences of the United States of America

Sabherwal N, Rowntree A, Marinopoulou E, Pettini T, Hourihane S, Thomas R, Soto X, Kursawe J, Papalopulu N.
PMID: 34725165
Proc Natl Acad Sci U S A. 2021 Nov 09;118(45). doi: 10.1073/pnas.2113527118.

Here, we study the dynamical expression of endogenously labeled Hes1, a transcriptional repressor implicated in controlling cell proliferation, to understand how cell-cycle length heterogeneity is generated in estrogen receptor (ER)

Cite
Sabherwal N, Rowntree A, Marinopoulou E, et al. Differential phase register of Hes1 oscillations with mitoses underlies cell-cycle heterogeneity in ER. Proc Natl Acad Sci U S A. 2021;118(45)doi: 10.1073/pnas.2113527118.
Sabherwal, N., Rowntree, A., Marinopoulou, E., Pettini, T., Hourihane, S., Thomas, R., Soto, X., Kursawe, J., & Papalopulu, N. (2021). Differential phase register of Hes1 oscillations with mitoses underlies cell-cycle heterogeneity in ER. Proceedings of the National Academy of Sciences of the United States of America, 118(45), . https://doi.org/10.1073/pnas.2113527118
Sabherwal, Nitin, et al. "Differential phase register of Hes1 oscillations with mitoses underlies cell-cycle heterogeneity in ER." Proceedings of the National Academy of Sciences of the United States of America vol. 118,45 (2021). doi: https://doi.org/10.1073/pnas.2113527118
Sabherwal N, Rowntree A, Marinopoulou E, Pettini T, Hourihane S, Thomas R, Soto X, Kursawe J, Papalopulu N. Differential phase register of Hes1 oscillations with mitoses underlies cell-cycle heterogeneity in ER. Proc Natl Acad Sci U S A. 2021 Nov 09;118(45). doi: 10.1073/pnas.2113527118. PMID: 34725165; PMCID: PMC8609326.
Copy Download .nbib Format: NLM
Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Zurzolo GA, Allen KJ, Taylor SL, Shreffler WG, Baumert JL, Tang ML, Gurrin LC, Mathai ML, Nordlee JA, Dunngalvin A, Hourihane JO.
PMID: 24028324
Allergy Asthma Clin Immunol. 2013 Sep 12;9(1):35. doi: 10.1186/1710-1492-9-35.

BACKGROUND: The eliciting dose (ED) for a peanut allergic reaction in 5% of the peanut allergic population, the ED05, is 1.5 mg of peanut protein. This ED05 was derived from oral food challenges (OFC) that use graded, incremental doses...

Cite
Zurzolo GA, Allen KJ, Taylor SL, et al. Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol. Allergy Asthma Clin Immunol. 2013;9(1):35doi: 10.1186/1710-1492-9-35.
Zurzolo, G. A., Allen, K. J., Taylor, S. L., Shreffler, W. G., Baumert, J. L., Tang, M. L., Gurrin, L. C., Mathai, M. L., Nordlee, J. A., Dunngalvin, A., & Hourihane, J. O. (2013). Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 9(1), 35. https://doi.org/10.1186/1710-1492-9-35
Zurzolo, Giovanni A, et al. "Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 9,1 (2013): 35. doi: https://doi.org/10.1186/1710-1492-9-35
Zurzolo GA, Allen KJ, Taylor SL, Shreffler WG, Baumert JL, Tang ML, Gurrin LC, Mathai ML, Nordlee JA, Dunngalvin A, Hourihane JO. Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol. Allergy Asthma Clin Immunol. 2013 Sep 12;9(1):35. doi: 10.1186/1710-1492-9-35. PMID: 24028324; PMCID: PMC3850217.
Copy Download .nbib Format: NLM
Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis.

The journal of allergy and clinical immunology. In practice

Turner PJ, Patel N, Ballmer-Weber BK, Baumert JL, Blom WM, Brooke-Taylor S, Brough H, Campbell DE, Chen H, Chinthrajah RS, Crevel RWR, Dubois AEJ, Ebisawa M, Elizur A, Gerdts JD, Gowland MH, Houben GF, Hourihane JOB, Knulst AC, La Vieille S, López MC, Mills ENC, Polenta GA, Purington N, Said M, Sampson HA, Schnadt S, Södergren E, Taylor SL, Remington BC.
PMID: 34438104
J Allergy Clin Immunol Pract. 2021 Aug 23; doi: 10.1016/j.jaip.2021.08.008. Epub 2021 Aug 23.

Regional and national legislation mandates the disclosure of "priority" allergens when present as an ingredient in foods, but this does not extend to the unintended presence of allergens due to shared production facilities. This has resulted in a proliferation...

Cite
Turner PJ, Patel N, Ballmer-Weber BK, et al. Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.08.008.
Turner, P. J., Patel, N., Ballmer-Weber, B. K., Baumert, J. L., Blom, W. M., Brooke-Taylor, S., Brough, H., Campbell, D. E., Chen, H., Chinthrajah, R. S., Crevel, R. W. R., Dubois, A. E. J., Ebisawa, M., Elizur, A., Gerdts, J. D., Gowland, M. H., Houben, G. F., Hourihane, J. O. B., Knulst, A. C., La Vieille, S., López, M. C., Mills, E. N. C., Polenta, G. A., Purington, N., Said, M., Sampson, H. A., Schnadt, S., Södergren, E., Taylor, S. L., & Remington, B. C. (2021). Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.08.008
Turner, Paul J, et al. "Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.08.008
Turner PJ, Patel N, Ballmer-Weber BK, Baumert JL, Blom WM, Brooke-Taylor S, Brough H, Campbell DE, Chen H, Chinthrajah RS, Crevel RWR, Dubois AEJ, Ebisawa M, Elizur A, Gerdts JD, Gowland MH, Houben GF, Hourihane JOB, Knulst AC, La Vieille S, López MC, Mills ENC, Polenta GA, Purington N, Said M, Sampson HA, Schnadt S, Södergren E, Taylor SL, Remington BC. Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis. J Allergy Clin Immunol Pract. 2021 Aug 23; doi: 10.1016/j.jaip.2021.08.008. Epub 2021 Aug 23. PMID: 34438104.
Copy Download .nbib Format: NLM
Food protein-induced enterocolitis syndrome in the British Isles.

Archives of disease in childhood

Stiefel G, Alviani C, Afzal NA, Byrne A, du Toit G, DunnGalvin A, Hourihane J, Jay N, Michaelis LJ, Erlewyn-Lajeunesse M.
PMID: 34446441
Arch Dis Child. 2021 Aug 26; doi: 10.1136/archdischild-2020-320924. Epub 2021 Aug 26.

BACKGROUND: Food protein-induced enterocolitis syndrome (FPIES) is a delayed type of food allergy, most often seen in infancy. We aimed to estimate its incidence, to describe common food triggers and the patient journeys of this rare but serious condition.DESIGN:...

Cite
Stiefel G, Alviani C, Afzal NA, et al. Food protein-induced enterocolitis syndrome in the British Isles. Arch Dis Child. 2021;doi: 10.1136/archdischild-2020-320924.
Stiefel, G., Alviani, C., Afzal, N. A., Byrne, A., du Toit, G., DunnGalvin, A., Hourihane, J., Jay, N., Michaelis, L. J., & Erlewyn-Lajeunesse, M. (2021). Food protein-induced enterocolitis syndrome in the British Isles. Archives of disease in childhood, . https://doi.org/10.1136/archdischild-2020-320924
Stiefel, Gary, et al. "Food protein-induced enterocolitis syndrome in the British Isles." Archives of disease in childhood vol. (2021). doi: https://doi.org/10.1136/archdischild-2020-320924
Stiefel G, Alviani C, Afzal NA, Byrne A, du Toit G, DunnGalvin A, Hourihane J, Jay N, Michaelis LJ, Erlewyn-Lajeunesse M. Food protein-induced enterocolitis syndrome in the British Isles. Arch Dis Child. 2021 Aug 26; doi: 10.1136/archdischild-2020-320924. Epub 2021 Aug 26. PMID: 34446441.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 28 entries